
WA led study sheds light on metabolic mechanisms behind Parkinson’s Disease
Emerging evidence indicates the important role of lipid metabolism dysregulation in driving the pathological features of Parkinson’s disease. A recent...
Continue reading
This website may not work correctly in Internet Explorer. We recommend switching to a more secure modern web browser such as Microsoft Edge which is already installed on your computer.
Perron Institute’s Media Centre displays media statements and is the central point of contact for journalists and media outlets seeking expert comments, latest research developments and other information.
All media enquiries should be directed to Perron Institute’s Communications Manager Tennille Kroemer on +61 426 044 223 or tennille.kroemer@perron.uwa.edu.au.
This contact information is for media outlets, publications, journalists and producers only. For all other enquiries, visit the Perron Institute contact page.

Emerging evidence indicates the important role of lipid metabolism dysregulation in driving the pathological features of Parkinson’s disease. A recent...

Researchers investigating why some people who carry a genetic variant known to cause motor neurone disease (MND) remain unaffected have...

A recent WA pilot study has found that pharmacogenetic (PGx) testing shows promise as a tool to support antidepressant prescribing...

A neuroprotective therapeutic being developed by Australian biotechnology company Argenica Therapeutics to reduce brain tissue death after stroke may also...

Golfing enthusiasts and novice players are set to tee off for a hole-in-one spectacle and a $500,000 prize at the...

A national facility to improve patients’ access to life-changing drugs and supercharge the development of biomedical innovations is being established...

An innovative exhibition that aims to present complicated science in a simple-to-understand and artistic way will be hosted by The...

Community-based approaches to dying and death will be explored in a free session to be held at the Cancer Council...

Peter Coghlan, a stroke and locked-in syndrome survivor who hiked the highest mountain in Wales last year, is now sharing...

Clinicians across Australia and New Zealand have published evidence of a non-invasive screening method for a common feature of cryptogenic...

High school students have demonstrated their knowledge of the brain and passion for science at the WA Brain Bee Challenge...

Argenica Therapeutics, the WA based biotechnology company developing novel therapeutics to reduce brain tissue death after stroke and other acute...
Stay up to date with our latest news and announcements.